Keywords: ipsen, medicis, submit, bla, reloxin, french, drugmaker

Ipsen and Medicis submit US BLA for Reloxin

Article | 10 December 2007

Print This

French drugmaker Ipsen and the USA's Medicis have submitted a Biologics License Application for their botulinum toxin type A product ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in